IvonneHSchulmanMD
Nephrology • Bethesda, MDAcute Renal Failure, Chronic Renal Failure & Dialysis, Hypertension
Program Director, NIH, NIDDK
Dr. Schulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
NIH
8800 Rockville Pike
Bethesda, MD 20814- Is this information wrong?
Education & Training
University of Miami/Jackson Health SystemFellowship, Nephrology, 2002 - 2004- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2000
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1997 - 1998
University of Miami Leonard M. Miller School of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 1999 - 2026
Awards, Honors, & Recognition
- AOA AOA Medical Honor Society
- Fellow American Heart Association
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Join now to see all
Clinical Trials
- AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery Start of enrollment: 2014 Mar 03
- Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure Start of enrollment: 2015 Oct 01
- Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects Start of enrollment: 2017 Oct 20
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsOptimizing the Design and Analysis of Future AKI Trials.Matthieu Legrand, Sean M Bagshaw, Jay L Koyner, Ivonne H Schulman, Michael R Mathis, Juliane Bernholz, Steven Coca, Martin Gallagher, Stéphane Gaudry, Kathleen D Liu, ...> ;Journal of the American Society of Nephrology. 2022 Aug 1
- Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.Angela C Rieger, Bryon A Tompkins, Makoto Natsumeda, Victoria Florea, Monisha N Banerjee, Jose Rodriguez, Marcos Rosado, Valeria Porras, Krystalenia Valasaki, Lauro M ...> ;Stem Cells Translational Medicine. 2022 Mar 3
- 11 citationsTransplantation Mediates Much of the Racial Disparity in Survival from Childhood-Onset Kidney Failure.Adan Z Becerra, Kevin E Chan, Paul W Eggers, Jenna Norton, Paul L Kimmel, Ivonne H Schulman, Susan R Mendley> ;Journal of the American Society of Nephrology. 2022 Jul 1
- Join now to see all
Journal Articles
- Insights Into Signaling in Cell-Based Therapy for Heart DiseaseRieger, A. C., Tompkins, B. A., Banerjee, M., Natsumeda, M., Florea, V., & Schulman, I. H., Signal Transduction Insights, 7/10/2017
Authored Content
- Stem Cell Therapies for Renal DiseasesJanuary 2019
- Unique Aspects of the Design of Phase I/II Clinical Trials of Stem Cell Therapy6/6/2018
- Allogeneic Mesenchymal Stem Cells as a Treatment for Aging Frailty8/30/2017
Press Mentions
American Society of Nephrology, Nov. 4 to 7November 19th, 2021
Menopause May Boost Salt-Linked HypertensionSeptember 23rd, 2005
Health News - Two New Miller School Studies Show How Stem Cell Injections Improve Heart StructureFebruary 10th, 2016
Professional Memberships
- Fellow
- Fellow
Other Languages
- Spanish
Hospital Affiliations
Jackson Health SystemMiami, Florida
University of Miami HospitalMiami, Florida
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
